Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio
May 25, 2024 06:15 ET
|
Novartis Pharma AG
In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor, demonstrated a statistically significant 36.1% proteinuria (protein in urine) reduction...
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo
May 25, 2024 06:00 ET
|
Novartis Pharma AG
Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label data to be presented at a future medical...
Nokia Oyj: Omien osakkeiden takaisinosto 24.05.2024
May 24, 2024 15:30 ET
|
Nokia Oyj
Nokia OyjPörssitiedote24.05.2024 klo 22.30 Nokia Oyj: Omien osakkeiden takaisinosto 24.05.2024 Espoo – Nokia Oyj (LEI: 549300A0JPRWG1KI7U06) on 24.05.2024 hankkinut omia osakkeitaan (ISIN...
Nokia Corporation: Repurchase of own shares on 24.05.2024
May 24, 2024 15:30 ET
|
Nokia Oyj
Nokia CorporationStock Exchange Release24 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 24.05.2024 Espoo, Finland – On 24 May 2024 Nokia Corporation (LEI:...
Net Asset Value(s)
May 24, 2024 12:32 ET
|
Foresight Enterprise VCT plc.
FORESIGHT ENTERPRISE VCT PLCLEI: 213800MWJNR3WZZ3ZP42 NAV ANNOUNCEMENT24 MAY 2024 The Board of Foresight Enterprise VCT plc announces that the unaudited Net Asset Value as at 24 May 2024 was 64.6p...
Transaction in Own Shares
May 24, 2024 12:08 ET
|
Shell plc
Transaction in Own Shares 24 May, 2024 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 24 May, 2024 it purchased the following number of Shares for cancellation. ...
Form 8.3 - Lok’n Store Group PLC
May 24, 2024 10:13 ET
|
Rathbones Group PLC
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Form 8.3 - Keywords Studios Plc
May 24, 2024 10:08 ET
|
Rathbones Group PLC
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Form 8.3 - GCP Asset Backed Income Fund Limited
May 24, 2024 10:04 ET
|
Rathbones Group PLC
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Form 8.3 - Balanced Commercial Property Trust Limited
May 24, 2024 10:03 ET
|
Rathbones Group PLC
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...